October 25, 2007 – Ceremed's Ostene, designed to stop bone bleeding in surgery, reportedly does not interfere with bone healing or increase the risk of surgical infections, including MRSA.
This FDA approved and CE marked novel biomaterial is used in cardiac, orthopedic, and neurosurgery and has additional applications as a safe, soluble delivery vehicle for a variety of therapeutic agents, from antibiotics to bone growth factors, according to the manufacturer.